Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 0 | 0 | 0 | 0 |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | 148.1M | 133.6M | 116.9M | 131.5M |
Selling general and admin | 32.7M | 28.6M | 23.0M | 21.5M |
Other operating expenses | — | — | -292K | -394K |
Operating income | -180.8M | -163.0M | -139.6M | -152.6M |
Non operating interest income | ||||
Income | 32.9M | 36.5M | 28.1M | 23.8M |
Expense | — | — | — | — |
Other income expense | 7.1M | -10.6M | 8.5M | 71K |
Pretax income | -140.7M | -137.1M | -103.1M | -128.7M |
Tax provision | — | — | — | — |
Net income | -140.7M | -137.1M | -103.1M | -128.7M |
Basic EPS | -1.0 | — | -0.8 | -1.1 |
Diluted EPS | -1.0 | — | -0.8 | -1.1 |
Basic average shares | 135.7M | — | 123.7M | 117.3M |
Diluted average shares | 135.7M | — | 123.7M | 117.3M |
EBITDA | -175.9M | -46.4M | -143.6M | -149.2M |
Net income from continuing op. | -140.7M | -137.1M | -103.1M | -128.7M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |